The FDA and AvKare have reported a recall of eye care products, including drops and artificial tears, from BRS Analytical ...

Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23, but the Food and Drug Administration listed it as a Class II on May 6, ...

AvKare did not specify what issues had been identified. The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned.

According to the FDA, over 75,000 cases of five different eye drops and artificial tears were recalled. Here's what you need ...

The FDA's website also lists the number of cases involved in the recall: 13,104 cases of Lubricant Eye Drops Solution (National Drug Code: 50268-126-15) The recalled items were first shipped between ...

Serbia's Novak Djokovic uses eye drops during a break as he plays Russia's Daniil Medvedev in the US Open tennis tournament men's singles final match at the USTA Billie Jean King National Tennis ...

In all, 75,795 cases have been recalled, or 1.8 million cartons of eye drops. The reason for the recall is the potential lack of sterility and cGMP deviations. The term cGMP stands for Current ...

If you’re a frequent eye drop user, now’s the time to check your medicine cabinet: The pharmaceutical lab BRS Analytical Service, LLC has issued a voluntary recall of five different ophthalmic ...

BRS Analytical Service announced that five ophthalmic solutions were recalled due to violations of current good manufacturing ...

The recalled products, which include eye drops and artificial tears, were distributed nationwide over the course of two years. Here's what Illinois consumers should know. St. Louis-based firm BRS ...